Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

Xeris Biopharma Holdings Inc. diskutieren

Xeris Biopharma Holdings Inc.

WKN: A3C4ZC / Symbol: XERS / Name: Xeris Biopharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

6,24 €
-2,30 %

12 0
12
0
Einschätzung Buy
Rendite (%) -7,00 %
Kursziel 8,58
Veränderung
Endet am 09.01.27

Xeris Biopharma (NASDAQ:XERS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for XERS provided by MarketBeat

HC Wainwright 
0
Melden Teilen
09.01.26
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

TD_Securities in AGF Management B Pfd NV diskutieren
AGF Management (OTCMKTS:AGFMF) had its "buy" rating reaf...
19:15
DA_Davidson in Bridgewater Bancshares Inc diskutieren
Bridgewater Bancshares (NASDAQ:BWB) had its "buy" rating...
19:00
Royal_Bank_of_Canada in AGF Management B Pfd NV diskutieren
AGF Management (OTCMKTS:AGFMF) had its "outperform" rati...
18:15
UBS_Group_AG in StoneCo Ltd diskutieren
StoneCo (NASDAQ:STNE) was given a new $19.50 price targe...
17:01
Barrington_Research in Discuss K12 Inc., Stride Inc.
Stride (NYSE:LRN) had its "outperform" rating reaffirmed...
16:00
China_Renaissance in Bloom Energy Corp diskutieren
Bloom Energy (NYSE:BE) is now covered by analysts at Chi...
15:03
Bank_of_America_Co_ in Celestica Inc. diskutieren
Celestica (NYSE:CLS) (TSE:CLS) is now covered by analyst...
15:03
Barclays_PLC in Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at...
15:03
Mehr anzeigen